Description
What is Rahika (Capmatinib)?
Capmatinib, is an anticancer medication used for the treatment of metastatic non-small cell lung cancer whose tumors have a mutation that leads to the exon 14 skipping of the MET gene, which codes for the membrane receptor HGFR.
The most common adverse reactions are peripheral edema, nausea, fatigue, vomiting, dyspnea, and decreased appetite. Capmatinib was approved for medical use in the United States in May 2020. Capmatinib is the first therapy approved by the US Food and Drug Administration (FDA) to treat non-small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
How to buy Rahika (Capmatinib) in India or Globally?
Buy Rahika (Capmatinib) directly from Aark Pharmaceuticals at discounted pricing.
Aark Pharmaceuticals, A Leading ISO. 9001.2008 approved C&F, distributors, stockist & retailer of anti-cancer, anti-HIV, life-saving medicines and medical and surgical devices. Our organization is customer-oriented and strongly believes in the quality and timely supply of superior medicines at an economical rate.
The order for Rahika (Capmatinib) will be confirmed only after the receipt of a valid prescription of the doctor and import permit if applicable.
What is the best price of Rahika (Capmatinib)?
Please contact us at +91 9999156233 or you can drop an email to us at sales@aarkpharma.com.